Joy Schechtman
Expertise in
36
conditions

Dr. Joy Schechtman

Sleep Medicine
6818 W Thunderbird Rd, 
Peoria, AZ 
Accepting New Patients
Offers Telehealth
Expertise in
36
conditions
6818 W Thunderbird Rd, 
Peoria, AZ 

Overview

Joy Schechtman is a Sleep Medicine provider in Peoria, Arizona. Dr. Schechtman is highly rated in 36 conditions, according to our data. Her top areas of expertise are Rheumatoid Arthritis (RA), Osteoporosis, Bursitis, and Postmenopausal Osteoporosis. Dr. Schechtman is currently accepting new patients.

Her clinical research consists of co-authoring 4 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution

Ohio Univ Coll Of Osteopathic Med.

Specialties

Sleep Medicine

Licenses

Internal Medicine in AZ

Board Certifications

American Os Bd Internal Medicine
American Os Bd Internal Medicine (Sub: Rheumatology)

Hospital Affiliations

Honor Health John C. Lincoln Medical Center

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health First
  • HMO
  • POS
Health Net

Accepted plan types not found. Please verify directly with the provider.

Highmark
  • EPO
  • HMO
  • PPO
HMSA
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
MercyCare
  • EPO
  • HMO
Oscar
  • EPO
  • HMO
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
VibrantRx
  • MEDICARE PDP
  • OTHER MEDICARE
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 22 Less Insurance Carriers -

Locations

Sun Valley Arthritis Center, LTD
6818 W Thunderbird Rd, Peoria, AZ 85381

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A Randomized, Controlled Pragmatic Phase 3b/4 Study of Baricitinib in Patients With Rheumatoid Arthritis
A Randomized, Controlled Pragmatic Phase 3b/4 Study of Baricitinib in Patients With Rheumatoid Arthritis
Enrollment Status: Completed
Publish Date: July 17, 2025
Intervention Type: Drug
Study Drugs: Baricitinib, TNF Inhibitor
Study Phase: Phase 4
EpiCeram for Skin Protection in Healthcare Workers Using Personal Protective Equipment
EpiCeram for Skin Protection in Healthcare Workers Using Personal Protective Equipment
Enrollment Status: Terminated
Publish Date: August 28, 2024
Intervention Type: Device
Study Phase: Not Applicable
A 52-week, Phase 3, Multicentre, Randomised, Double Blind, Efficacy and Safety Study Comparing GSK3196165 With Placebo and With Tofacitinib, in Combination With Methotrexate in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
A 52-week, Phase 3, Multicentre, Randomised, Double Blind, Efficacy and Safety Study Comparing GSK3196165 With Placebo and With Tofacitinib, in Combination With Methotrexate in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
Enrollment Status: Completed
Publish Date: March 27, 2024
Intervention Type: Biological, Drug
Study Drugs: GSK3196165, Tofacitinib, Methotrexate, Folic acid
Study Phase: Phase 3
A 24-week, Phase 3, Multicentre, Randomised, Double-blind, Efficacy and Safety Study, Comparing GSK3196165 With Placebo and With Sarilumab, in Combination With Conventional Synthetic DMARDs, in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Biological DMARDs and/or Janus Kinase Inhibitors
A 24-week, Phase 3, Multicentre, Randomised, Double-blind, Efficacy and Safety Study, Comparing GSK3196165 With Placebo and With Sarilumab, in Combination With Conventional Synthetic DMARDs, in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Biological DMARDs and/or Janus Kinase Inhibitors
Enrollment Status: Completed
Publish Date: July 17, 2023
Intervention Type: Drug, Biological
Study Drugs: GSK3196165, Sarilumab, csDMARDs
Study Phase: Phase 3
A Randomized, Non-inferiority, Phase 3, Open-label, Multicenter Study to Evaluate the Efficacy and Safety of Abaloparatide-sMTS for the Treatment of Postmenopausal Women With Osteoporosis (the wearABLe Study)
A Randomized, Non-inferiority, Phase 3, Open-label, Multicenter Study to Evaluate the Efficacy and Safety of Abaloparatide-sMTS for the Treatment of Postmenopausal Women With Osteoporosis (the wearABLe Study)
Enrollment Status: Completed
Publish Date: February 15, 2023
Intervention Type: Combination product
Study Drugs: Abaloparatide solid microstructured transdermal system, Abaloparatide subcutaneous
Study Phase: Phase 3
Safety and Effectiveness of Live Zoster Vaccine in Anti-TNF Users (VERVE Trial)
Safety and Effectiveness of Live Zoster Vaccine in Anti-TNF Users (VERVE Trial)
Enrollment Status: Completed
Publish Date: November 23, 2021
Intervention Type: Drug, Biological
Study Drug: Zostavax Herpes Zoster Vaccine
Study Phase: Phase 2
Diosmiplex (Vasculera®) in Primary and Secondary Raynaud's Phenomenon
Diosmiplex (Vasculera®) in Primary and Secondary Raynaud's Phenomenon
Enrollment Status: Completed
Publish Date: August 17, 2017
Intervention Type: Dietary supplement, Other
Study Phase: Not Applicable
View 6 Less Clinical Trials

4 Total Publications

Effectiveness and safety of intravenous golimumab with and without concomitant methotrexate in patients with rheumatoid arthritis in the prospective, noninterventional AWARE study.
Effectiveness and safety of intravenous golimumab with and without concomitant methotrexate in patients with rheumatoid arthritis in the prospective, noninterventional AWARE study.
Journal: BMC rheumatology
Published: May 23, 2022
Similar Doctors
Expertise in
43
conditions
Dr. Arun Kumar
Sleep Medicine
Expertise in
43
conditions
Dr. Arun Kumar
Sleep Medicine

Valley Institute Of Neurology PLLC

6750 E Baywood Ave Ste 502, 
Mesa, AZ 
 (31.8 miles away)
480-854-7100
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Arun Kumar is a Sleep Medicine provider in Mesa, Arizona. Dr. Kumar is highly rated in 43 conditions, according to our data. His top areas of expertise are Spinocerebellar Ataxia Type 2, Spinocerebellar Ataxia Type 23, Spinocerebellar Ataxia Type 14, Spinocerebellar Ataxia Type 8, and Angioplasty.

Expertise in
22
conditions
Dr. Raj Mulpuri
Sleep Medicine
Expertise in
22
conditions
Dr. Raj Mulpuri
Sleep Medicine

Valley Sleep Center

13203 N 103rd Ave Ste I1-B, 
Sun City, AZ 
 (4.5 miles away)
480-830-3900
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Raj Mulpuri is a Sleep Medicine provider in Sun City, Arizona. Dr. Mulpuri is highly rated in 22 conditions, according to our data. His top areas of expertise are Lung Nodules, Coccidioidomycosis, Lung Metastases, Chronic Obstructive Pulmonary Disease (COPD), and Advanced Bronchoscopy. Dr. Mulpuri is currently accepting new patients.

Expertise in
6
conditions
Dr. Chad Ruoff
Sleep Medicine
Expertise in
6
conditions
Dr. Chad Ruoff
Sleep Medicine

Mayo Clinic Building Scottsdale

13400 E Shea Blvd, 
Scottsdale, AZ 
 (23.7 miles away)
480-301-8000
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Chad Ruoff is a Sleep Medicine provider in Scottsdale, Arizona. Dr. Ruoff is highly rated in 6 conditions, according to our data. His top areas of expertise are Drowsiness, Narcolepsy, Obstructive Sleep Apnea, and Excessive Daytime Sleepiness.

Frequently Asked Questions about Dr. Joy Schechtman

How do I make an appointment with Dr. Joy Schechtman?

You can book an appointment with Dr. Joy Schechtman by calling their office at 623-566-3550. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Joy Schechtman a top-rated expert for Rheumatoid Arthritis (RA)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Joy Schechtman is classified as an Distinguished expert for Rheumatoid Arthritis (RA), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Joy Schechtman specialize in?

While Dr. Joy Schechtman is a Sleep Medicine, they have specific expertise in Rheumatoid Arthritis (RA), Osteoporosis, and Bursitis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Sleep Medicine.

Does Dr. Joy Schechtman participate in research or clinical trials?

Yes. Dr. Joy Schechtman has published 4 articles and abstracts on conditions like Rheumatoid Arthritis (RA). You can view a list of Dr. Joy Schechtman's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Joy Schechtman accept my insurance?

Dr. Joy Schechtman accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 623-566-3550 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Schechtman's expertise for a condition
ConditionClose
    View All 15 Distinguished Conditions
    View All 21 Advanced Conditions
    View All 31 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile